Yorkshire Cancer Research Bowel Cancer Improvement Program

Not Applicable

• Conditions: Colorectal cancer; Cancer

• Registration Number: ISRCTN15907802
• Lead Sponsor: niversity of Leeds

Brief Summary

2019 Protocol article in http://dx.doi.org/10.1136/bmjopen-2019-030618 protocol (added 16/09/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-31
• Last Update Posted: 26 September 2023
• Study Completion: 2025-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

For the observational, population-based aspects of the study:
1. A diagnosis of bowel cancer (ICD 10 code C18, 19 or C20)
2. Resident in the Yorkshire and Humber region and managed by one of the sixteen bowel cancer MDTs who are participating in the study.

For prospective cohort aspects of the study:
1. A diagnosis of bowel cancer (ICD 10 code C18, 19 or C20)
2. Close to the time of diagnosis and before primary treatment commences (unless the individual presents urgently and undergoes an emergency resection)
3. Considered suitable for treatment
4. English literate

Exclusion Criteria

1. Patients under 18 years of age
2. Patients with a diagnosis of anal cancer (ICD-10 code C21)
3. Patients who are not-resident within Yorkshire and the Humber study region and who have not been diagnosed and managed by one of the sixteen bowel cancer MDTs who participating in the study
4. In addition for the prospective cohort aspects will exclude patient who lacks the capacity to give informed consent (this may be due, for example, to psychopathology, cognitive dysfunction or learning difficulties)

Study & Design

• Study Type: Observational
• Study Design: Not specified